Insider Cluster (5 insiders) ·Filed Jun 15, 2026

ONC

BeOne Medicines Ltd.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3mo ago
Insider cluster: 5 insiders, $2.0M total
Actionable Insight • Neutral

The insider selling is immaterial and likely driven by routine tax or diversification planning following equity grants. No actionable signal for traders; monitor for any material corporate events that might prompt larger-scale insider activity.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
ONC ▲ +29.51% at T+60d
NEUTRAL call ✓ call won +29.51% · α vs SPY +28.51% · entry $263.92 → $341.80
Entry anchored
Jun 15, 03:59 PM ET
via exchange tick
T+1d
-0.47%
call -0.47% · α +0.78%
$262.68
settled 4mo ago
T+5d
+4.63%
call +4.63% · α +6.86%
$276.13
settled 3mo ago
T+20d
+16.16%
call +16.16% · α +15.96%
$306.56
settled 3mo ago
T+60d
+29.51%
call +29.51% · α +28.51%
$341.80
settled 22d ago

Price Chart

Loading chart...

Executive Summary

Five BeOne Medicines insiders, including the CEO, sold a total of $1.98M in open-market shares over a one-week window. The selling is trivial relative to the $29.4B market cap (0.007%), and the cluster is accompanied by large equity grants to the same executives, suggesting routine compensation-related liquidity rather than a bearish signal.

Key Financial Metrics

Direction
selling
Total Value
$2.0M
Insiders
5

Key Facts

  • CEO John Oyler sold $1.03M worth of shares on 2026-06-08.
  • Total open-market sales by 5 insiders: $1.98M.
  • Total sales represent ~0.007% of ONC's $29.4B market cap.
  • Multiple executives received large equity grants (non-cash) on the same date as some sales.
  • Prior insider cluster reports on ONC have had negative T+20 outcomes, but this cluster is too small to be informative.

Financial Impact

Total insider sales of $1.98M, negligible relative to $29.4B market cap.

insider ownership

Risk Factors

  • Insider selling could accelerate if executives perceive headwinds, but current levels are insignificant.

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations
Analyst Consensus
92% bullish (12 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ONC-1781560626867
19 reports for ONC
Performance horizon
60% Hit rate 3 of 5 directional calls best @ T+20▲ +10.46%Aug 5, 2026
Filters
Rows
Reports for ONC — sortable, filterable
TypeNow
Sep 10, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$346.51 $350.84▲ +1.25%▲ +1.47%$358.07 (+3.34%)
Sep 3, 2026
29d ago
Insider Cluster
NEUTRAL ★ 2/10
$362.68 $346.51▼ −4.46%▼ −3.31%$358.07 (−1.27%)
Aug 26, 2026
5w ago
8-K
NEUTRAL ★ 2/10
$375.80 $361.78▼ −3.73%▼ −3.61%$358.07 (−4.72%)
Aug 14, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$347.48 $374.47▲ +7.77%▲ +9.14%$358.07 (+3.05%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 4/10
$356.01 $369.16▲ +3.69%▲ +5.66%$358.07 (+0.58%)
Aug 10, 2026
7w ago
144
BEARISH ★ 6/10
$359.27 $369.15▼ −2.75%▼ −3.15%$358.07 (+0.33%)
Aug 5, 2026
8w ago
Insider Cluster
NEUTRAL ★ 2/10
$329.80 $356.01▲ +7.95%▲ +6.73%$358.07 (+8.57%)
Aug 5, 2026
8w ago
8-K
BULLISH ★ 7/10
$327.53 $359.05▲ +9.62%▲ +9.27%$358.07 (+9.32%)
Jul 24, 2026
10w ago
Insider Cluster
NEUTRAL ★ 2/10
$325.90 $322.08▼ −1.17%▼ −1.55%$358.07 (+9.87%)
Jul 17, 2026
11w ago
Insider Cluster
BEARISH ★ 5/10
$312.02 $326.77▼ −4.73%▼ −5.41%$358.07 (−14.76%)
Showing 10 of 19

US Market Status

Market Closed — Opens Mon (65h 6m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jun 15, 2026